期刊
AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 114, 期 3, 页码 530-532出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.14309/ajg.0000000000000068
关键词
-
资金
- Cancer Prevention & Research Institute of Texas grant [RP150587]
- Center for Gastrointestinal Development, Infection and Injury [NIDDK P30 DK 56338]
OBJECTIVES:The Texas Hepatocellular Carcinoma Consortium cohort study investigates risk factors of hepatocellular carcinoma (HCC) and biomarkers for early HCC detection in patients with liver cirrhosis.METHODS:Adult patients with liver cirrhosis are enrolled at 5 clinical centers from 3 cities in Texas, with a target of 5,000 patients. Clinical history, risk factor questionnaires, liver imaging, laboratory data, and blood samples were collected at enrollment and at each 6-month follow-up visit.RESULTS:The primary outcome was the development of HCC. Biomarkers were tested in banked blood samples using prospective specimen collection, retrospective blinded evaluation design.CONCLUSIONS:We describe study design, eligibility criteria, recruitment, study cores, and sample size and analysis considerations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据